Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-11-01
|
| Series: | Journal of Translational Medicine |
| id |
doaj-ecfa75b12c4647b7ad2dfd703eaa2f59 |
|---|---|
| record_format |
Article |
| spelling |
doaj-ecfa75b12c4647b7ad2dfd703eaa2f592020-11-25T02:46:16ZengBMCJournal of Translational Medicine1479-58762010-11-018Suppl 1P3710.1186/1479-5876-8-S1-P37Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assaysNesbitt AFossati G |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Nesbitt A Fossati G |
| spellingShingle |
Nesbitt A Fossati G Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays Journal of Translational Medicine |
| author_facet |
Nesbitt A Fossati G |
| author_sort |
Nesbitt A |
| title |
Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays |
| title_short |
Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays |
| title_full |
Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays |
| title_fullStr |
Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays |
| title_full_unstemmed |
Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays |
| title_sort |
certolizumab pegol has a different profile from other anti-tnfs, including golimumab, in a variety of in vitro assays |
| publisher |
BMC |
| series |
Journal of Translational Medicine |
| issn |
1479-5876 |
| publishDate |
2010-11-01 |
| work_keys_str_mv |
AT nesbitta certolizumabpegolhasadifferentprofilefromotherantitnfsincludinggolimumabinavarietyofinvitroassays AT fossatig certolizumabpegolhasadifferentprofilefromotherantitnfsincludinggolimumabinavarietyofinvitroassays |
| _version_ |
1724759452842721280 |